GlassScriptPhysician profile
Sarah Dawn Pace
NPI 1598081705
$3,911.22
in general payments reported to CMS, 2019-2025
34 companies · $947 in 2025
The $947 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $45.81 · 2021: $38.28 · 2022: $222 · 2023: $1,217 · 2024: $1,159 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,322.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $667.58 | 2022-2025 | Mounjaro, Trulicity, Jardiance |
| Astrazeneca Pharmaceuticals LP | $491.46 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $397.02 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $275.41 | 2022-2025 | Evenity, Prolia, Repatha |
| Radius Health, INC. | $177.92 | 2023-2025 | Tymlos |
| Abbvie INC. | $158.87 | 2023-2025 | |
| Exact Sciences Corporation | $157.91 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.72 | 2023-2025 | Jardiance |
| Embecta Corp. | $157.17 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Insulet Corporation | $132.32 | 2024-2025 | Omnipod |
| Pfizer INC. | $109.79 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $107.96 | 2024-2025 | Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $94.51 | 2023-2025 | |
| Edwards Lifesciences Corporation | $88.37 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Xeris Pharmaceuticals, INC. | $87.26 | 2023-2025 | Recorlev, Gvoke Hypopen |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $81.91 | 2024-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $79.96 | 2023-2025 | |
| Glaxosmithkline, LLC. | $70.95 | 2024 | Arexvy, Shingrix |
| Kyowa Kirin, INC. | $45.84 | 2023-2025 | Crysvita |
| Antares Pharma, INC. | $35.13 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Abiomed | $31.72 | 2025 | |
| Inari Medical, INC. | $31.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $31.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.93 | 2020 | |
| Tandem Diabetes Care, INC. | $28.94 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Rhythm Pharmaceuticals, INC. | $24.96 | 2025 | Imcivree |
| Medtronic, INC. | $23.43 | 2023 | Minimed 780g |
| Amarin Pharma, INC. | $22.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.40 | 2021 | |
| Dexcom, INC. | $21.02 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $18.89 | 2025 | Gardasil 9, Capvaxive |
| Beta Bionics, INC. | $18.77 | 2023 | Ilet Bionic Pancreas |
| Esperion Therapeutics, INC. | $16.88 | 2021 | |
| Hologic Sales and Service, LLC | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.